Company Filing History:
2 out of 157 
2 out of 1,289 
1 out of 832,812 Years Active: 2001-2006
Title: The Innovative Mind of Irmingard Sures
Introduction
Irmingard Sures, an accomplished inventor based in Munich, Germany, has made significant contributions to the field of biomedicine. With a portfolio of three patents, she has focused on the intricate workings of cytoplasmic tyrosine kinases, which play crucial roles in cellular signal transduction.
Latest Patents
One of Irmingard's notable inventions is centered around megakaryocytic protein tyrosine kinase I. This invention pertains to novel cytoplasmic tyrosine kinases isolated from megakaryocytes, known as megakaryocyte kinases (MKKs). These kinases, identified as MKK1, MKK2, and MKK3, are integral to various cellular signaling pathways. Her work emphasizes the potential of these proteins in the diagnosis and treatment of diseases, marking an important advancement in therapeutic applications.
Career Highlights
Throughout her career, Irmingard has been associated with prominent institutions such as Sugen Incorporated and the Max Planck Society for the Advancement of Science. Her roles in these organizations have facilitated groundbreaking research and the exploration of innovative medical solutions.
Collaborations
Irmingard has collaborated with notable individuals in the field, including Axel Ullrich and Mikhail L Gishizky. These partnerships have likely enhanced her research output and contributed to her success as an inventor.
Conclusion
Irmingard Sures stands out in the realm of innovative inventors, with a focused contribution to the understanding of tyrosine kinases. Her patents not only highlight her expertise but also promise significant advancements in the medical field, aiding in the diagnosis and treatment of various diseases.